Dr. Darcy V. Spicer, MD

Dr. Spicer practices at Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles.

Dr. Spicer's NPI, 1568407179, was assigned on June 18, 2006. Dr. Spicer graduated from University of Calgary Faculty of Medicine in 1975. Dr. Spicer holds California license G39950.

Dr. Spicer's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Room C2K100, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 226-2800.

Dr. Spicer's primary practice is Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles. Dr. Spicer is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Spicer to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spicer practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Spicer's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Spicer is board certified in internal medicine by the American Board of Internal Medicine. Dr. Spicer is licensed in California.

Dmand AI lists breast cancer and chronic anemia among the conditions Dr. Spicer treats.

CMS data shows 257 Medicare services from Dr. Spicer across 3 procedure codes in 2024, all of them office visits, for 126 Medicare patients. Medicare paid $19,355 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Spicer in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have cancer, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spicer's median patient age at 65, with 72% women.

In 2024, Dr. Spicer wrote 72 Medicare Part D claims for 24 patients. 93% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $312 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Spicer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Spicer, published from 2018 to 2025. The most frequent topics are Breast Neoplasms. Dr. Spicer's most frequent co-authors are Foluso Olabisi Ademuyiwa, MD, Batul Hamza Al-Zubeidy, MD and Karam Ashouri, MD.

Dmand AI links Dr. Spicer to 3 clinical trials. Conditions studied include Breast Neoplasms, Hematologic Neoplasms and Breast Diseases.

CMS Open Payments shows 9 general payments to Dr. Spicer from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 95% of the total. Bristol-Myers Squibb Company paid the most, $78.

Dr. Spicer serves on Scientific Conduct Committee Keck School of Medicine University of Southern California, Research Review Subcommittee Institutional Review Board Keck School of Medicine University of Southern California Health Sciences Campus and Pharmacy and Therapeutics Committee USC Norris Cancer Hospital.

Dr. Spicer graduated from University of Calgary Faculty of Medicine in 1975. Dr. Spicer is a member of ACP and ASCO.

Dr. Spicer is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.